Evolution of the Average Target: Galectin Therapeutics Inc.

Evolution of the Target Price: Galectin Therapeutics Inc.

Changes in Analyst Recommendations: Galectin Therapeutics Inc.

c3b3.I1RCR-kHRudgXF3OgZw6KhBzZ_Usi8b39KRwiU4gwhY.Uxx7Aa1BF940DhmZwMVPTVogFsVg_qChnsYy7CpjnXpTMzsln042sBkSBA~586d54e6f253b1d5e8d0e519d955672e

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- - +268.51%
+22.34%
+7%
+20.58%
+29.2%
+42.47%
+25.91%
+1.17%
+5.39%
+18.31%
Average +44.09%
Weighted average by Cap. +20.88%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
2.985USD
Average target price
11.00USD
Spread / Average Target
+268.51%
High Price Target
11.00USD
Spread / Highest target
+268.51%
Low Price Target
11.00USD
Spread / Lowest Target
+268.51%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

HC Wainwright
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
2.985USD
Average target price
11.00USD
Spread / Average Target
+268.51%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. GALT Stock
  4. Consensus Galectin Therapeutics Inc.